|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups
|
Luke Timmerman |
12/22/11 |
Seattle
|
|
Jive, Solaria, Awe.sm: Bay Area Biztech News by the Numbers
|
Wade Roush |
12/01/11 |
San Francisco
|
|
Melinda Moree Steps Down as CEO of BIO Ventures for Global Health
|
Luke Timmerman |
11/18/11 |
Seattle
|
|
A Look Ahead for Washington State’s Life Sciences Cluster
|
Thong Le |
11/16/11 |
Seattle
|
|
Klip: iPhone Video Sharing Refined to A High Art
|
Wade Roush |
11/11/11 |
National
|
|
Dendreon Shares Tank Again, Elias Joins Gates Foundation, Seattle Children’s Gets $50M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
11/03/11 |
Seattle
|
|
PATH CEO Chris Elias Resigns For Top Anti-Poverty Job at Gates Foundation
|
Luke Timmerman |
10/31/11 |
Seattle
|
|
Wanderfly’s Technology Feeds Wanderlust on The New York Times’s Travel Pages
|
João-Pierre S. Ruth |
10/12/11 |
New York
|
|
How Seattle Set Out to Create a Biotech Hub and Fostered a Global Health Nexus
|
Don Rule |
08/08/11 |
Seattle
|
|
Ken Stuart, the Working Class Kid Who Built a Global Health Hotspot at Seattle Biomed
|
Luke Timmerman |
07/20/11 |
Seattle
|
|
PATH Partners With GSK on Malaria Vaccine
|
Luke Timmerman |
06/06/11 |
Seattle
|
|
Resolve Maps Out New Biotech Model, SeaGen Expands, Schadt Heads East, & More in Seattle-Area Life Sciences News
|
Luke Timmerman |
05/19/11 |
Seattle
|
|
Finding a Solution To Our Biotech Malaise Together
|
Richard Gayle |
05/18/11 |
Seattle
|
|
PATH VP Takes CEO Gig at Global Impact
|
Luke Timmerman |
05/17/11 |
Seattle
|
|
Geospiza Sells to PerkinElmer, PATH Vaccine Nabs $100M, Halosource Gets China Approval, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
05/12/11 |
Seattle
|
|
PATH Meningitis Vaccine Gets $100M
|
Luke Timmerman |
05/11/11 |
Seattle
|
|
“Consumer Surplus” from Personal Technology Is Soaring in the Age of Appreciation
|
Wade Roush |
03/25/11 |
National
|
|
Gates Foundation Makes First Equity Investment in a Biotech Startup, Liquidia Technologies
|
Luke Timmerman |
03/08/11 |
Seattle
|
|
Obama’s Earmark Ban Could Ripple Through Northwest Makers of Vaccines, Biofuels, Clean Water Technology
|
Curt Woodward |
02/24/11 |
Seattle
|
|
Washington’s Innovation Corridor a Key to Recovery
|
Chris Rivera |
02/18/11 |
Seattle
|
|
Cooliris Dilates by $9.6M
|
Wade Roush |
02/14/11 |
San Francisco
|
|
Path Pockets $8.65M
|
Wade Roush |
02/02/11 |
San Francisco
|
|
Path Obtains $8,500,000 Series A Funding Round
|
VentureDeal |
02/01/11 |
San Francisco
|
|
Path Adds Video
|
Wade Roush |
12/22/10 |
San Francisco
|
|
Seattle Genetics’ Home Run, NanoString’s Diagnostics Foray, PATH’s 50-Cent Vaccine, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
12/09/10 |
Seattle
|
|
Watch Out Big Pharma: PATH, WHO Show that Nonprofits Can Develop New Meningitis Vaccine
|
Luke Timmerman |
12/08/10 |
Seattle
|
|
Accelerator’s East Coast Foray, Gates Foundation Bets on RSV Vaccine, UW Sues GE, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
12/02/10 |
Seattle
|
|
See You Tonight at “Biotech’s Back in Seattle”
|
Luke Timmerman |
11/29/10 |
Seattle
|
|
Only a Few Tickets Left for Xconomy “Biotech’s Back in Seattle” Event on Nov. 29
|
Luke Timmerman |
11/24/10 |
Seattle
|
|
Path Debuts, Stipple and PayNearMe Tank Up, Facebook Sends a Message, & More Bay-Area BizTech News
|
Wade Roush |
11/22/10 |
San Francisco
|
|
Page 1 of
4 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.